SLC30A8 and type 2 diabetes mellitus: Genetic studies in participants of European descent identified two rare protein-truncating SLC30A8 variants, Arg138Ter and Lys34SerfsTer50, for which heterozygosity was associated with 53% and 80% risk reduction for type 2 diabetes, respectively [8, 10].